Bioactive Self‐Assembled Nanoregulator Enhances Hematoma Resolution and Inhibits Neuroinflammation in the Treatment of Intracerebral Hemorrhage

Abstract Hematoma and secondary neuroinflammation continue to pose a significant challenge in the clinical treatment of intracerebral hemorrhage (ICH). This study describes a nanoregulator formed through the self‐assembly of Mg2+ and signal regulatory protein α (SIRPα) DNAzyme (SDz), aimed at enhanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenyan Yu, Chengyuan Che, Yi Yang, Yuzhen Zhao, Junjie Liu, Aibing Chen, Jinjin Shi
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202408647
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553176771166208
author Wenyan Yu
Chengyuan Che
Yi Yang
Yuzhen Zhao
Junjie Liu
Aibing Chen
Jinjin Shi
author_facet Wenyan Yu
Chengyuan Che
Yi Yang
Yuzhen Zhao
Junjie Liu
Aibing Chen
Jinjin Shi
author_sort Wenyan Yu
collection DOAJ
description Abstract Hematoma and secondary neuroinflammation continue to pose a significant challenge in the clinical treatment of intracerebral hemorrhage (ICH). This study describes a nanoregulator formed through the self‐assembly of Mg2+ and signal regulatory protein α (SIRPα) DNAzyme (SDz), aimed at enhancing hematoma resolution and inhibiting neuroinflammation in the treatment of ICH. The structure of SDz collapses in response to the acidic endo/lysosomal microenvironment of microglia, releasing Mg2+ and the SIRPα DNAzyme. The Mg2+ then acts as a cofactor to activate the SIRPα DNAzyme. By blocking the CD47‐SIRPα signaling pathway, microglia can rapidly and effectively phagocytose red blood cells (RBCs), thereby promoting the clearance of the hematoma. Simultaneously, Mg2+ reset the microglia to the M2 phenotype by inhibiting the MYD88/MAPK/NF‐κB signaling pathway, thereby modulating the inflammatory microenvironment of ICH. This co‐delivery and synergistic strategy resulted in a significant reduction in hematoma size, decreasing from 11.90 to 5.84 mm3, and promoted recovery from ICH with minimal systemic side effects. This simple yet highly effective nanoplatform, which involves complex synergistic mechanisms, proves to be effective for ICH therapy and holds great promise for introducing novel perspectives into clinical and translational approaches for ICH.
format Article
id doaj-art-b829cd3ff54748a38500b76bcc87aacb
institution Kabale University
issn 2198-3844
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-b829cd3ff54748a38500b76bcc87aacb2025-01-09T11:44:45ZengWileyAdvanced Science2198-38442025-01-01121n/an/a10.1002/advs.202408647Bioactive Self‐Assembled Nanoregulator Enhances Hematoma Resolution and Inhibits Neuroinflammation in the Treatment of Intracerebral HemorrhageWenyan Yu0Chengyuan Che1Yi Yang2Yuzhen Zhao3Junjie Liu4Aibing Chen5Jinjin Shi6School of Pharmaceutical Sciences Zhengzhou University Zhengzhou 450001 ChinaCollege of Chemical and Pharmaceutical Engineering Hebei University of Science and Technology Shijiazhuang 050018 ChinaSchool of Pharmaceutical Sciences Zhengzhou University Zhengzhou 450001 ChinaSchool of Pharmaceutical Sciences Zhengzhou University Zhengzhou 450001 ChinaSchool of Pharmaceutical Sciences Zhengzhou University Zhengzhou 450001 ChinaCollege of Chemical and Pharmaceutical Engineering Hebei University of Science and Technology Shijiazhuang 050018 ChinaSchool of Pharmaceutical Sciences Zhengzhou University Zhengzhou 450001 ChinaAbstract Hematoma and secondary neuroinflammation continue to pose a significant challenge in the clinical treatment of intracerebral hemorrhage (ICH). This study describes a nanoregulator formed through the self‐assembly of Mg2+ and signal regulatory protein α (SIRPα) DNAzyme (SDz), aimed at enhancing hematoma resolution and inhibiting neuroinflammation in the treatment of ICH. The structure of SDz collapses in response to the acidic endo/lysosomal microenvironment of microglia, releasing Mg2+ and the SIRPα DNAzyme. The Mg2+ then acts as a cofactor to activate the SIRPα DNAzyme. By blocking the CD47‐SIRPα signaling pathway, microglia can rapidly and effectively phagocytose red blood cells (RBCs), thereby promoting the clearance of the hematoma. Simultaneously, Mg2+ reset the microglia to the M2 phenotype by inhibiting the MYD88/MAPK/NF‐κB signaling pathway, thereby modulating the inflammatory microenvironment of ICH. This co‐delivery and synergistic strategy resulted in a significant reduction in hematoma size, decreasing from 11.90 to 5.84 mm3, and promoted recovery from ICH with minimal systemic side effects. This simple yet highly effective nanoplatform, which involves complex synergistic mechanisms, proves to be effective for ICH therapy and holds great promise for introducing novel perspectives into clinical and translational approaches for ICH.https://doi.org/10.1002/advs.202408647drug deliveryhematoma clearanceintracerebral hemorrhage therapymicroglia polarizationnanotechnology
spellingShingle Wenyan Yu
Chengyuan Che
Yi Yang
Yuzhen Zhao
Junjie Liu
Aibing Chen
Jinjin Shi
Bioactive Self‐Assembled Nanoregulator Enhances Hematoma Resolution and Inhibits Neuroinflammation in the Treatment of Intracerebral Hemorrhage
Advanced Science
drug delivery
hematoma clearance
intracerebral hemorrhage therapy
microglia polarization
nanotechnology
title Bioactive Self‐Assembled Nanoregulator Enhances Hematoma Resolution and Inhibits Neuroinflammation in the Treatment of Intracerebral Hemorrhage
title_full Bioactive Self‐Assembled Nanoregulator Enhances Hematoma Resolution and Inhibits Neuroinflammation in the Treatment of Intracerebral Hemorrhage
title_fullStr Bioactive Self‐Assembled Nanoregulator Enhances Hematoma Resolution and Inhibits Neuroinflammation in the Treatment of Intracerebral Hemorrhage
title_full_unstemmed Bioactive Self‐Assembled Nanoregulator Enhances Hematoma Resolution and Inhibits Neuroinflammation in the Treatment of Intracerebral Hemorrhage
title_short Bioactive Self‐Assembled Nanoregulator Enhances Hematoma Resolution and Inhibits Neuroinflammation in the Treatment of Intracerebral Hemorrhage
title_sort bioactive self assembled nanoregulator enhances hematoma resolution and inhibits neuroinflammation in the treatment of intracerebral hemorrhage
topic drug delivery
hematoma clearance
intracerebral hemorrhage therapy
microglia polarization
nanotechnology
url https://doi.org/10.1002/advs.202408647
work_keys_str_mv AT wenyanyu bioactiveselfassemblednanoregulatorenhanceshematomaresolutionandinhibitsneuroinflammationinthetreatmentofintracerebralhemorrhage
AT chengyuanche bioactiveselfassemblednanoregulatorenhanceshematomaresolutionandinhibitsneuroinflammationinthetreatmentofintracerebralhemorrhage
AT yiyang bioactiveselfassemblednanoregulatorenhanceshematomaresolutionandinhibitsneuroinflammationinthetreatmentofintracerebralhemorrhage
AT yuzhenzhao bioactiveselfassemblednanoregulatorenhanceshematomaresolutionandinhibitsneuroinflammationinthetreatmentofintracerebralhemorrhage
AT junjieliu bioactiveselfassemblednanoregulatorenhanceshematomaresolutionandinhibitsneuroinflammationinthetreatmentofintracerebralhemorrhage
AT aibingchen bioactiveselfassemblednanoregulatorenhanceshematomaresolutionandinhibitsneuroinflammationinthetreatmentofintracerebralhemorrhage
AT jinjinshi bioactiveselfassemblednanoregulatorenhanceshematomaresolutionandinhibitsneuroinflammationinthetreatmentofintracerebralhemorrhage